Cargando…
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
In the last decade, the advent of biological targeted therapies has revolutionized the management of several types of cancer, especially in the realm of hematologic malignancies. One of these pathways, and the center of this review, is the phosphatidylinositol-3-kinase (PI3K) pathway. The PI3K pathw...
Autores principales: | Castillo, Jorge J, Iyengar, Meera, Kuritzky, Benjamin, Bishop, Kenneth D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937185/ https://www.ncbi.nlm.nih.gov/pubmed/24591840 http://dx.doi.org/10.2147/OTT.S34641 |
Ejemplares similares
-
Two isotypes of phosphatidylinositol 3‐phosphate‐binding sorting nexins play distinct roles in trogocytosis in Entamoeba histolytica
por: Watanabe, Natsuki, et al.
Publicado: (2019) -
The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011) -
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
por: Adamo, Barbara, et al.
Publicado: (2011) -
The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
por: Zeinalzadeh, Elham, et al.
Publicado: (2021) -
FRI610 Phosphatidylinositol 3-kinase Inhibition With Alpelisib Is Safe And Effective In Treating Refractory Hypoglycemia Associated With Malignant Insulinoma
por: Mi Kang, Yu, et al.
Publicado: (2023)